179 related articles for article (PubMed ID: 31411787)
1. The psychosexual impact of testing positive for high-risk cervical human papillomavirus (HPV): A systematic review.
Bennett KF; Waller J; Ryan M; Bailey JV; Marlow LAV
Psychooncology; 2019 Oct; 28(10):1959-1970. PubMed ID: 31411787
[TBL] [Abstract][Full Text] [Related]
2. Exploring the psychosexual impact and disclosure experiences of women testing positive for high-risk cervical human papillomavirus.
Bennett KF; Waller J; Bailey JV; Marlow LAV
Br J Health Psychol; 2023 Feb; 28(1):62-79. PubMed ID: 35819012
[TBL] [Abstract][Full Text] [Related]
3. Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
Bennett KF; Waller J; McBride E; Forster AS; Di Gessa G; Kitchener H; Marlow L
BJOG; 2021 Mar; 128(4):745-754. PubMed ID: 32783300
[TBL] [Abstract][Full Text] [Related]
4. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
[TBL] [Abstract][Full Text] [Related]
5. Social and psychological impact of HPV testing in cervical screening: a qualitative study.
McCaffery K; Waller J; Nazroo J; Wardle J
Sex Transm Infect; 2006 Apr; 82(2):169-74. PubMed ID: 16581749
[TBL] [Abstract][Full Text] [Related]
6. Concerns about disclosing a high-risk cervical human papillomavirus (HPV) infection to a sexual partner: a systematic review and thematic synthesis.
Bennett KF; Waller J; Ryan M; Bailey JV; Marlow LAV
BMJ Sex Reprod Health; 2020 Jan; 47(1):17-26. PubMed ID: 31915190
[TBL] [Abstract][Full Text] [Related]
7. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
8. "If you can't treat HPV, why test for it?" Women's attitudes to the changing face of cervical cancer prevention: a focus group study.
McRae J; Martin C; O'Leary J; Sharp L;
BMC Womens Health; 2014 May; 14():64. PubMed ID: 24885650
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
10. Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening.
O'Connor M; O'Leary E; Waller J; Gallagher P; Martin CM; O'Leary JJ; Sharp L;
Prev Med; 2018 Oct; 115():90-96. PubMed ID: 30144488
[TBL] [Abstract][Full Text] [Related]
11. Iranian women's psychological responses to positive HPV test result: a qualitative study.
Qaderi K; Mirmolaei ST; Geranmayeh M; Sheikh Hasani S; Farnam F
BMC Womens Health; 2021 Mar; 21(1):128. PubMed ID: 33771159
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine.
Jradi H; Bawazir A
Vaccine; 2019 Jan; 37(3):530-537. PubMed ID: 30503079
[TBL] [Abstract][Full Text] [Related]
13. Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis.
McBride E; Tatar O; Rosberger Z; Rockliffe L; Marlow LAV; Moss-Morris R; Kaur N; Wade K; Waller J
Health Psychol Rev; 2021 Sep; 15(3):395-429. PubMed ID: 32449477
[TBL] [Abstract][Full Text] [Related]
14. "Knowing that I had HPV, I literally just shut down": A qualitative exploration of the psychosocial impact of human papillomavirus (HPV) in women living with mental health conditions.
O'Donnell N; Waller J; Marlow L; Anderson NC; McBride E
Br J Health Psychol; 2024 Feb; 29(1):80-94. PubMed ID: 37658582
[TBL] [Abstract][Full Text] [Related]
15. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
16. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
17. A reproductive justice approach to understanding women's experiences with HPV and cervical cancer prevention.
Sundstrom B; Smith E; Delay C; Luque JS; Davila C; Feder B; Paddock V; Poudrier J; Pierce JY; Brandt HM
Soc Sci Med; 2019 Jul; 232():289-297. PubMed ID: 31121439
[TBL] [Abstract][Full Text] [Related]
18. HPV primary cervical screening in England: Women's awareness and attitudes.
Patel H; Moss EL; Sherman SM
Psychooncology; 2018 Jun; 27(6):1559-1564. PubMed ID: 29521462
[TBL] [Abstract][Full Text] [Related]
19. Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Ogilvie GS; Smith LW; van Niekerk D; Khurshed F; Pedersen HN; Taylor D; Thomson K; Greene SB; Babich SM; Franco EL; Coldman AJ
BMC Public Health; 2016 Mar; 16():213. PubMed ID: 26935960
[TBL] [Abstract][Full Text] [Related]
20. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.
O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):134-41. PubMed ID: 25248873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
